Grant✓ Small businesses may apply
NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional)
National Institutes of Health
- Opportunity #
- RFA-HL-26-002
- Agency
- National Institutes of Health
- ALN (CFDA)
- 93.840, 93.838, 93.839, 93.837, 93.233
- Status
- posted
- Posted
- Apr 26, 2024
- Closes
- Apr 28, 2027
- Funding instrument
- Grant
- Category
- Health
- Cost sharing required
- No
Who can apply
- •County governments
- •Public housing authorities/Indian housing authorities
- •Special district governments
- •Independent school districts
- •Others (see text field entitled "Additional Information on Eligibility" for clarification)
- •Native American tribal organizations (other than Federally recognized tribal governments)
- •Private institutions of higher education
- •Public and State controlled institutions of higher education
- •City or township governments
- •Small businesses
- •For profit organizations other than small businesses
- •State governments
- •Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- •Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- •Native American tribal governments (Federally recognized)
Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Synopsis
The purpose of the NHLBI Outstanding Investigator Award (OIA) is to promote scientific productivity and innovation by providing long-term support and increased flexibility to experienced Program Directors/Principal Investigators (PDs/PIs) who are currently PDs/PIs on at least two NHLBI R01-equivalent awards and whose outstanding record of research demonstrates their ability to make major contributions to heart, lung, blood and sleep (HLBS) research. The OIA is intended to support a research program, rather than a research project, by providing the primary and most likely sole source of NHLBI funding on individual grant awards.
The OIA will support the research program of NHLBI-funded investigators for up to seven years. The OIA will provide investigators increased freedom to conduct research that breaks new ground or extends previous discoveries in new directions. It will also allow PDs/PIs to take greater risks and to pursue research that requires a longer timeframe. Research supported by the OIA must be within the scope of the NHLBI mission (https://www.nhlbi.nih.gov/about/mission-statement).
It is anticipated that the OIA will:
Provide a stable funding environment, thereby improving productivity and facilitating nimble, ambitious, creative research;
Accelerate scientific innovation by enabling flexibility in pursuing new research directions as they arise, since PDs/PIs will not be bound to specific aims proposed in advance of the studies;
Reduce the time researchers spend writing grant applications and managing multiple grant awards, thereby allowing more time to be devoted to conducting research;
Facilitate commitment of PDs/PIs to research through increased stability of funding; and
Enable PDs/PIs to devote more time and energy to mentoring students and junior scientists and providing scientific service.
Contact
National Institutes of Health · grantsinfo@nih.gov